pak 104p has been researched along with nad in 1 studies
Studies (pak 104p) | Trials (pak 104p) | Recent Studies (post-2010) (pak 104p) | Studies (nad) | Trials (nad) | Recent Studies (post-2010) (nad) |
---|---|---|---|---|---|
16 | 0 | 0 | 30,121 | 88 | 5,663 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adès, D; Garnier-Suillerot, A; Le Moyec, L; Migonney, V; Saengkhae, C; Salerno, M; Siove, A | 1 |
1 other study(ies) available for pak 104p and nad
Article | Year |
---|---|
Ability of carbazole salts, inhibitors of Alzheimer beta-amyloid fibril formation, to cross cellular membranes.
Topics: Alzheimer Disease; Amyloid beta-Peptides; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Carbazoles; Cell Membrane; Cell Membrane Permeability; Cell Nucleus; Circular Dichroism; Cyclic P-Oxides; DNA; Glutathione; Humans; K562 Cells; Membrane Potentials; Multidrug Resistance-Associated Proteins; NAD; Nicotinic Acids; Oxidation-Reduction; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Time Factors; Triazoles | 2007 |